Acceptability of formulations and application methods for vaginal microbicides among drug-involved women: Results of product trials in three cities

Sexually Transmitted Diseases

Volumn 27, Issue 2, 2000, Pages 119-126

  Hammett, Theodore M ^a   Mason, Theresa H ^a   Joanis, Carol L ^b   Foster, Susan E ^a   Harmon, Patricia ^a   Robles, Rafaela R ^c   Finlinson, H Ann ^c   Feudo, Rudy ^d   Vining Bethea, Sandra ^d   Jeter, Garry ^d   Mayer, Kenneth H ^e   Doherty Iddings, Paula ^e   Seage III, George R ^a,f  

^a ABT ASSOCIATES   (United States)

^b FAMILY HEALTH INTERNATIONAL   (United States)

^c SCHOOL OF MEDICINE   (Puerto Rico)

^d Gtr Bridgeport Adol Pregnancy P   (United States)

^e MEMORIAL HOSPITAL OF RHODE ISLAND   (United States)

^f BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; BUFFER; CARRAGEENAN; DEXTRIN; LUBRIN; MOIST AGAIN; OCTOXINOL; REPLENS; UNCLASSIFIED DRUG;

ADULT; ARTICLE; DRUG DEPENDENCE; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; PATIENT SATISFACTION; SEXUAL BEHAVIOR; SEXUALITY; SEXUALLY TRANSMITTED DISEASE;

EID: 0033964936     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-200002000-00011     Document Type: Article

References (39)

1. Centers for Disease Control and Prevention. HIV/AIDS Surveillance Report 1997; 9:12.
2. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR 1997; 46:165-73.
3. Stein ZA. HIV prevention: the need for methods women can use. Am J Public Health 1990; 80:460-462.
4. Stein ZA. HIV prevention: an update on the status of methods women can use. Am J Public Health 1993; 83:1379-1382.
5. Coggins C, Elias C. Atisook R, et al. A study of women's preferences regarding the formulation of over-the-counter vaginal spermicides. New York: Population Council, 1998.
6. Stephenson J. US AIDS research office chief: intensify vaccine, prevention research. JAMA 1998; 280:1211-1213.
7. Nathanson N. Harnessing research to control AIDS. Nat Med 1998; 4:879-81.
8. Lurie P, Reingold AL, Bowser B, et al. The public health impact of needle exchange programs in the United States and abroad. Berkeley and San Francisco: University of California School of Public Health and Institute for Health Policy Studies. Report prepared for: the Centers for Disease Control and Prevention, Atlanta, 1993.
9. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348:987-991.
10. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18(suppl 1):37-44.
11. Vlahov D, Junge B. The role of needle exchange programs in HIV prevention. Public Health Rep 1998; 113(suppl 1):75-80.
12. Worth D. Sexual decision-making and AIDS: why condom promotion among vulnerable women is likely to fail. Stud Farn Plann 1989; 20: 297-307.
13. Kane S. AIDS, addictions and condom use: sources of sexual risk for heterosexual women. J Sex Res 1990; 27:427-444.
14. Gollub EL, Stein Z, El-Sadr W. Short-term acceptability of the female condom among staff and patients at a New York City hospital. Fam Plann Perspect 1995; 27:155-158.
15. Farr G. Gabelnick H, Sturgen K, Dorflinger L. Contraceptive efficacy and acceptability of the female condom. Am J Public Health 1994; 84:1960-1964.
16. Roddy RE, Zekeng L, Ryan KA, Tamoufe U, Weir SS, Wong EL. A controlled trial of nonoxynol-9 film to reduce male-to-female transmission of sexually transmitted diseases. N Engl J Med 1998; 339:504-10.
17. Wittkowski KM, Susser E, Dietz K. The protective effect of condoms and nonoxynol-9 against HIV infection. Am J Public Health 1998; 88:590-596.
18. Mayer K, Peipert J, Fleming T, Cu-Uvin S, Horton S, Moench T, Rosenberg Z. BufferGel: results of the first phase I study of a novel vaginal microbicide (abstract no. 33158), Poster presented at: the 12th World AIDS Conference, Geneva, July 1, 1998.
19. Mason TH, Foster S, Finlinson HA, Morrow KM, Vining-Bethea S, Seage GR. Factors affecting acceptability of vaginal microbicides among drug involved women: results of focus groups in three cities (abstract no. 33154). Poster presented at: the 12th World AIDS Conference, Geneva, July 1, 1998.
20. Steiner M, Spruyt A, Joanis C, Glover L, Cordero M, Alvarado G, Onoka C. Acceptability of spermicidal film and foaming tablets among women in three countries. Int Fam Plann Perspect 1995; 21:104-107.
21. Williamson NE, Joanis C. Acceptability of barrier methods for prevention of unwanted pregnancy and infection. In: Mauck CK, Cordero M, Gablenick HL, Spieler JM, Rivera R, eds. Barrier Contraceptives: Current Status and Future Prospects. New York: Wiley-Liss Publications, 1994: 53-67.
22. Mayer KH, Koblin B, Marmor M, Donnell D, Chiasson MA, Flanigan T. Contraceptive practices among U. S. women at increased risk for HIV acquisition (abstract no. Th.C.4510). Poster presented at: the XI International Conference on AIDS, Vancouver, July 11, 1996.
23. Tortu S, Beardsley M, Deren S, Davis WR. The risk of HIV infection in a national sample of women with injection drug-using partners. Am J Public Health 1994; 84:1243-1249.
24. Fullilove RE, Thompson Fullilove M, Bowser BP, Gross SA. Risk of sexually transmitted disease among black adolescent crack users in Oakland and San Francisco, California. JAMA 1990; 263:851-855.
25. Nyamathi AM, Lewis C, Leake B, Flaskerud J, Bennett C. Barriers to condom use and needle cleaning among impoverished minority female injection drug users and partners of injection drug users. Public Health Rep 1995; 110:166-172.
26. Paone D, Caloir S, Shi Q, Des Jarlais D. Sex, drugs, and syringe exchange in New York City: women's experiences. J Am Med Womens Assoc 1995; 50:109-114.
27. Zierler S. Women, sex, and HIV. Epidemiology 1994; 5:565-567.
28. Ramjee G, Abdool Karim SS, Morar NS. Acceptability of a vaginal microbicide among sex workers in Kwazulu Natal, South Africa (abstract no. 33151). Poster presented at: the 12th World AIDS Conference, Geneva, July 1, 1998.
29. Cain VS, Williamson NE. Issues of acceptability and behavior working group report. In: Mauck CK, Cordero M, Gablenick HL, Spieler JM, Rivera R, eds. Barrier Contraceptives: Current Status and Future Prospects. New York: Wiley-Liss Publishers, 1994:323-337.
30. Centers for Disease Control and Prevention. Contraceptive method and condom use among women at risk for HIV infection and other STDs - selected U.S. sites, 1993-1994. MMWR 1996; 45:820-823.
31. He H, McCoy HV, Stevens SJ, Stark MJ. Violence and HIV sexual risk behaviors among female sex partners of male drug users. Women Health 1998; 27:161-167.
32. Wagstaff DA, Kelly JA, Perry MJ, Sikkema KJ, Solomon LJ, Heckman TG, Anderson ES, and the Community Housing AIDS Prevention Study Group. Multiple partners, risky partners and HIV risk among low-income urban women. Farn Plann Perspect 1995; 27: 241-245.
33. Severy L, Thapa S. Preferences and tolerance as determinants of contraceptive acceptability. Adv Popul 1994; 2:119-139.
34. Chen LC, Snow RC. Benefits and risks of the pill: perception and reality. Adv Contracept 1992; 7:19-34.
35. Chesney M, Bentley ME, Morrow KM, Mayer K. Real experience: the key to microbicide acceptability (abstract no. 33152). Poster presented at: the 12th World AIDS Conference, Geneva, July 1, 1998.
36. Macalino GE, Celentano D, Hilton C, McFadden C, Vlahov D. Vaginal microbicide use: knowledge and attitudes in a cohort of intravenous drug users (abstract no. Th.C.4508). Poster presented at: the XI International Conference on AIDS, Vancouver, July 11, 1996.
37. Gollub E, French P, Rogers C, Latka M, Stein ZA. Reduced STD reinfection and more protected acts with a choice of methods: the women's risk reduction hierarchy (abstract no. 331531). Poster presented at: the 12th World AIDS Conference, Geneva, July 1, 1998.
38. Gollub EL. Women-centered prevention techniques and technologies. In: O'Leary A, Jemmott LS, eds. Women At Risk: Issues in the Primary Prevention of AIDS. New York: Plenum Press, 1995:43-82.
39. Heise, L. Beyond acceptability: users' perspectives on contraception. London: Reproductive Health Matters, 1997.